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Most autoimmune diseases in human are poly-
genic, and multiple genetic alterations are in-
volved in the initiation and progression of these 
diseases. Spontaneous animal models of auto-
immune diseases are useful for the elucidation 
of genetic basis of autoimmune diseases because 
they have all genetic alterations required for   
the overt autoimmune diseases. To date, various 
kinds  of  animals  that  spontaneously  develop 
autoimmune diseases have been selected, fixed, 
and used. Although most of them are regulated 
by many genetic alterations, as in human poly-
genic  autoimmune  diseases,  there  are  a  few 
models that are regulated by a single genetic al-
teration. Each genetic alteration in the latter 
type of model has a stronger influence on im-
mune system than those in the former type of 
models, making it relatively easy to identify the 
causal mutation and to elucidate its function in 
immunological  tolerance.  For  example,  the 
forkhead box P3 gene (Foxp3) has been iden-
tified  as  a  causal  gene  of  the  scurfy  mouse 
(Brunkow et al., 2001), which led to the deeper 
understanding of not only regulatory T cells   
(T reg cells) but also follicular helper T cells 
(Fontenot et al., 2003; Hori et al., 2003; Khattri 
et al., 2003; Tsuji et al., 2009). However, the 
number of such models is quite limited.
Programmed  cell  death  1  (PD-1;  mouse 
gene, Pdcd1), an immunoreceptor belonging to 
the CD28/cytotoxic T lymphocyte antigen 4 
(CTLA-4; mouse gene, Ctla4) family, provides 
negative costimulation to antigen stimulation 
(Okazaki and Honjo, 2006; Keir et al., 2008). 
PD-1 knockout (Pdcd1/) mice develop lupus-
like glomerulonephritis and arthritis on the 
C57BL/6  background,  autoimmune  dilated   
cardiomyopathy (DCM) and gastritis on the 
BALB/c background, acute type 1 diabetes mel-
litus (T1DM) on the nonobese diabetic (NOD) 
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Stimulatory and inhibitory co-receptors play fundamental roles in the regulation of the 
immune system. We describe a new mouse model of spontaneous autoimmune disease. 
Activation-induced cytidine deaminase–linked autoimmunity (aida) mice harbor a loss- 
of-function mutation in the gene encoding lymphocyte activation gene 3 (LAG-3), an 
inhibitory co-receptor. Although LAG-3 deficiency alone did not induce autoimmunity in 
nonautoimmune-prone mouse strains, it induced lethal myocarditis in BALB/c mice defi-
cient for the gene encoding the inhibitory co-receptor programmed cell death 1 (PD-1).  
In addition, LAG-3 deficiency alone accelerated type 1 diabetes mellitus in nonobese dia-
betic mice. These results demonstrate that LAG-3 acts synergistically with PD-1 and/or 
other immunoregulatory genes to prevent autoimmunity in mice.
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but of a spontaneous loss-of-function mu-
tation, which we named AID-linked auto-
immunity (aida), in a neighboring gene, lymphocyte activation 
gene 3 (LAG-3; mouse gene, Lag3). Although LAG-3 defi-
ciency alone did not induce autoimmunity in nonautoimmune-
prone strains, it induced lethal myocarditis in the absence of 
PD-1 on the BALB/c background. In addition, LAG-3 defi-
ciency alone exaggerated the onset and the penetrance of 
T1DM in NOD mice. These results indicate that LAG-3 is a 
critical regulator of autoimmunity and that it acts synergisti-
cally with PD-1 and/or other immune regulators to prevent 
autoimmunity in mice.
RESULTS
AID deficiency exaggerated autoimmune phenotypes of NOD 
mice and Pdcd1/ mice
To analyze the roles of SHM and CSR of autoAb in the   
development  of  gastritis  and  DCM,  we  crossed  BALB/c-
Pdcd1/ with BALB/c-Aicda/ mice, which are defective 
in both the SHM and CSR (Muramatsu et al., 2000; Fagarasan 
et  al.,  2002).  Unexpectedly,  all  of  the  BALB/c-Pdcd1/ 
Aicda/ mice died before 10 wk of age (Fig. 1 A). Autopsy 
examination  revealed  that  all  of  the  BALB/c-Pdcd1/ 
Aicda/ mice exhibited dilatation of the heart, with occa-
sional thrombus formation in the atrium, pleural effusion, as-
cites, and congested liver, suggesting congestive heart failure 
as the cause of premature death. Histological examination re-
vealed massive lymphocytic infiltration into the atrium and 
ventricle of the heart (Fig. 1 B). Lymphocyte infiltration was 
also occasionally found in the stomach, salivary gland, pancreas, 
lung, and liver, with little to no tissue destruction (Fig. S1).   
Intriguingly, 60% of BALB/c-Pdcd1/Aicda+/ mice died 
of myocarditis, suggesting that AID protects mice from auto-
immunity in a dose-dependent manner. To analyze the PD-1–
independent  effect  of  the AID  deficiency,  we  backcrossed 
BALB/c-Aicda/ mice on the NOD background. Both female 
and male NOD-Aicda/ mice developed T1DM much faster 
than NOD wild-type mice, and all of the NOD-Aicda/ 
mice developed T1DM before 13 wk of age (Fig. 1 C).   
background, and lethal myocarditis on the MRL background 
(Okazaki and Honjo, 2006; Wang et al., 2010), suggesting that 
PD-1 deficiency acts synergistically with other genetic altera-
tions inherent to each strain to induce strain-specific auto-
immune diseases.
Because autoimmune diseases in Pdcd1/ mice frequently 
accompany the production of tissue-specific autoantibodies 
(autoAbs; Okazaki et al., 2003, 2005), they may provide espe-
cially useful insights on the regulation of autoreactive B cells. 
One of the unique features of B cells is the introduction of 
genetic modifications into immunoglobulin genes after mat-
uration. The affinity of Ab to its cognate antigen can be 
improved by random somatic hypermutation (SHM) on im-
munoglobulin heavy and light chain genes and subsequent 
selection of B cell clones with increased affinity for the anti-
gen. In addition, the isotype of Abs can be changed by class 
switch recombination (CSR) of immunoglobulin heavy chain 
constant region gene, which endows Abs with diverse effector 
functions (Honjo et al., 2002). Both of these genetic modifi-
cations are introduced by activation-induced cytidine deami-
nase (AID; mouse gene, Aicda), and Aicda/ mice are defective 
in both SHM and CSR (Muramatsu et al., 1999, 2000). SHM 
and CSR are expected to play essential roles in the devel-
opment of autoimmunity because isotype-switched and so-
matically mutated autoAbs are hallmarks of antigen-specific 
immune responses and they are frequently found in human 
patients and model animals of systemic and organ-specific au-
toimmune diseases (Shlomchik et al., 1990; van Es et al., 1991; 
Stott et al., 1998). However, the roles of SHM and CSR in 
autoimmune diseases are still controversial (Jiang et al., 2007; 
Chen et al., 2010).
In the present study, we crossed BALB/c-Pdcd1/ with 
BALB/c-Aicda/ mice to analyze the roles of SHM and 
CSR in the development of gastritis and DCM. Unexpect-
edly, all of the BALB/c-Pdcd1/Aicda/ mice died of severe 
myocarditis before 10 wk of age. However, subsequent analy-
ses revealed this effect was not the result of AID deficiency 
Figure 1.  Spontaneous development of auto-
immune diseases in AID-deficient mice.  
(A) Survival curves of BALB/c-Pdcd1/Aicda/ 
(n = 32), BALB/c-Pdcd1/Aicda+/ (n = 20), 
BALB/c-Pdcd1+/Aicda/ (n = 28), and BALB/c 
wild-type (n = 13) mice. (B) Representative his-
tology of the heart from BALB/c wild-type and 
BALB/c-Pdcd1/Aicda/ mice. (C) Incidence of 
type 1 diabetes in NOD-Aicda/, NOD-Aicda+/, 
and NOD wild-type female (left, n = 9, 20, and 16, 
respectively) and male (right, n = 13, 36, and 16, 
respectively) mice. (D) The percentage of islets 
with each grade of insulitis (0, 1, 2, and 3) in 
female NOD wild-type (+/+) and NOD-Aicda/ 
(/) mice at 7 wk of age. More than 200 islets 
from five NOD wild-type and six NOD-Aicda/ 
mice were analyzed.JEM VOL. 208, February 14, 2011 
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each female F2 progeny to its F1 father. As expected, some 
mating pairs yielded only myocarditis-susceptible BALB/c-
Pdcd1/Aicda/ mice and the others yielded only myocarditis-
resistant BALB/c-Pdcd1/Aicda/ mice. We used BALB/c- 
Pdcd1+/Aicda/  mice  from  each  type  of  litters  for  the 
subsequent mating and established myocarditis-resistant (lines 
K and Y) and -susceptible (lines D and X) lines. We could also 
isolate T1DM-resistant and -susceptible lines of NOD-MT-
Aicda/ mice.
Identification of LAG-3 as a causal gene of aida mice
Because  the  Aicda/  mice  were  generated  by  disrupting 
Aicda in TT2 ES cells, which were established from (CBA × 
C57BL/6)F1 embryo (Yagi et al., 1993), the origin of the 
chromosome  surrounding  Aicda  was  C57BL/6,  CBA,  or 
Histological examination revealed more severe insulitis in the 
NOD-Aicda/ than in the NOD wild-type mice, confirm-
ing that the exacerbation of T1DM was a result of the aug-
mented autoimmune response against the  cells in islets   
(Fig. 1 D). Again, we observed a dose effect of AID on the 
regulation of T1DM.
AID deficiency exaggerated autoimmunity in the absence  
of B cells
We previously reported that Aicda/ mice show hyperplasia 
of the isolated lymphoid follicles (ILFs), with a 100-fold ex-
pansion of anaerobic flora (Fagarasan et al., 2002). Therefore, 
we examined the effect of flora on the acceleration of auto-
immunity by generating germ-free NOD-Aicda/ mice. 
Against our expectations, the germ-free NOD-Aicda/ mice 
developed T1DM at a comparable frequency to that of litter-
mate NOD-Aicda/ mice that had been moved from the 
germ-free to a specific pathogen-free (SPF) environment at   
5 wk of age (Fig. 2 A). Therefore, the exaggeration of T1DM 
by the AID deficiency was not a result of the expansion of 
commensal microorganisms. Next, we examined the involve-
ment of B cells by crossing B cell–deficient NOD-MT mice 
with NOD-Aicda/ mice. Surprisingly, the AID deficiency 
also accelerated the onset of T1DM in the absence of B cells, 
suggesting that the AID deficiency affects non–B cells to ac-
celerate T1DM (Fig. 2 B). Because recent findings suggest 
that AID functions in nonlymphoid as well as lymphoid   
tissues (Okazaki et al., 2002; Endo et al., 2007; Matsumoto   
et al., 2007), we hypothesized that AID modifies the antige-
nicity of a certain  cell antigen by introducing somatic mu-
tations. However, the adoptive transfer of BM cells from NOD 
wild-type mice induced T1DM with a similar time course   
in NOD-SCID and NOD-SCID-Aicda/ mice, whereas 
the adoptive transfer of BM cells from NOD-Aicda/ mice   
induced T1DM in NOD-SCID mice more quickly (Fig. 2 C). 
In addition, adoptive transfer experiments showed that the 
effector cells of myocarditis in the BALB/c-Pdcd1/Aicda/ 
mice were CD4+ T cells (Fig. 2 D). These results suggested 
that the AID deficiency affects T cells, rather than B cells, to 
accelerate autoimmunity.
Isolation of autoimmune-resistant lines of Aicda/ mice 
and establishment of aida mice
Among >50 BALB/c-Pdcd1/Aicda/ mice generated, one 
male mouse survived longer than 20 wk, suggesting that the 
acceleration of autoimmunity was not a result of the defect in 
AID function but of a mutation in another gene closely asso-
ciated with Aicda. We named this mutation aida for AID-
linked autoimmunity and tried to isolate myocarditis-resistant 
and -susceptible lines. Because this myocarditis-free male 
mouse was expected to be heterozygous for aida, we mated 
this mouse with female BALB/c-Pdcd1/ mice to obtain 
male BALB/c-Pdcd1/Aicda+/ mice, half of which were 
expected to carry a single aida locus. We further mated these 
male F1 progenies with female BALB/c wild-type mice to 
obtain female BALB/c-Pdcd1+/Aicda+/ mice and backcrossed 
Figure 2.  B cells are not required for the spontaneous develop-
ment of autoimmune diseases in AID-deficient mice. (A) Incidence of 
type 1 diabetes by 18 wk in female (left) and male (right) NOD-Aicda/ 
(/), NOD-Aicda+/ (+/), and NOD wild-type (+/+) mice that were 
kept in germ-free conditions (GF; n = 13, 9, and 8 for female and n = 10, 5, 
and 12 for male mice, respectively) or moved to SPF conditions (GF => 
SPF) at 5 wk of age (n = 11, 17, and 5 for female and n = 5, 17, and 6 for 
male mice, respectively). (B) Incidence of type 1 diabetes in NOD-MT-
Aicda/, NOD-MT-Aicda+/, and NOD-MT female (n = 13, 26, and 10, 
respectively) and male (n = 10, 24, and 17, respectively) mice. Ighm, im-
munoglobulin heavy constant mu gene. (C) Incidence of type 1 diabetes in 
NOD-SCID recipients of wild-type NOD BM (+/+ => +/+, n = 12) and 
NOD-SCID-Aicda/ recipients of wild-type NOD BM (+/+ => /,  
n = 14), and NOD-SCID recipients of NOD-Aicda/ BM (/ => +/+, n = 4). 
(D) Incidence of myocarditis by 7 wk after the adoptive transfer of total  
(n = 4), CD4+ (n = 10), or CD4-depleted (n = 19) spleen cells from mori-
bund BALB/c-Pdcd1/Aicda/ mice into BALB/c-Rag2/ mice.398 LAG-3 influences autoimmunity in mice | Okazaki et al.
the region between Aicda (122,514,197 bp) and rs37864878 
(Fig. 3 B). Because there are nearly 100 genes in this region, 
we selected genes that are expected to engage in immune 
response and sequenced their exons (Table S1). We found a 
2-bp deletion in the LAG-3 gene (124,854,379 bp) of the 
disease-susceptible line (Fig. 3 C; Triebel et al., 1990). Against 
our expectations, the deletion was not found in the genomes 
of the TT2 embryonic stem cells or the CBA wild-type mice 
(Fig. 3 D and not depicted). In addition, the deletion was not 
found in the genomes of C57BL/6-Pdcd1/Aicda/ mice 
that did not show any overt autoimmune phenotypes by   
24 wk of age (unpublished data). Collectively, it is likely that 
this deletion was accidentally introduced into CBA-derived 
Lag3 and passed on together with the knockout allele of   
Aicda in the course of backcrossing onto the BALB/c back-
ground. The 2-bp deletion was predicted to cause a frame 
shift  and  introduce  a  premature  stop  codon  right  after 
the first immunoglobulin fold of LAG-3 (Fig. 3, E and F).   
BALB/c  in  the  BALB/c-Aicda/  mice  and  C57BL/6,   
CBA, BALB/c, or NOD in the NOD-Aicda/ mice. Because 
microsatellite marker analyses revealed that the targeting con-
struct of Aicda was integrated into CBA-derived chromosome 
(unpublished data) and the disease-resistant lines were isolated 
in the course of backcrossing on BALB/c and NOD strains, 
the aida mutation was likely an inherent polymorphism of the 
CBA strain. Therefore, we sought to determine the origin of 
the chromosome in disease-susceptible and -resistant lines 
more in detail using microsatellite and single nucleotide poly-
morphism (SNP) markers.
Among >50 markers examined, D6Mit300 distinguished 
the disease-resistant and -susceptible lines. As expected, dis-
ease susceptibility was associated with the CBA allele at 
D6Mit300 (122,941,371 bp from the centromere; Fig. 3 A). 
Because both disease-susceptible and -resistant lines har-
bored  the  BALB/c-derived  chromosome  at  rs37864878 
(125,714,481 bp), the causal gene was expected to exist in 
Figure 3.  Identification of a 2-bp deletion in 
the LAG-3 gene. (A) Presence of CBA- or BALB/c- 
derived alleles at D6Mit300 in myocarditis-susceptible 
(X and D) and -resistant (Y and K) mouse lines  
was analyzed by simple sequence length poly-
morphism (SSLP). Representative data of more than 
three independent experiments are shown.  
(B) Origins of the chromosomal regions for the 
myocarditis-resistant (top) and -susceptible (bot-
tom) BALB/c-Pdcd1/Aicda/ lines. CBA, yellow; 
undetermined, red; BALB/c, gray. The causal gene 
was mapped between Aicda and rs37864878.  
(C) Sequencing of the mouse LAG-3 gene of  
disease-susceptible (top) and -resistant (bottom) 
mouse lines, with a reference sequence (http://ncbi 
.nlm.nih.gov). Bases deleted in susceptible strain 
are boxed. Representative data of more than three 
independent experiments are shown. (D) Restriction 
fragment length polymorphism (RFLP) analysis of 
the LAG-3 gene in BALB/c wild-type mice, BALB/c- 
Lag3+/aida mice, BALB/c-Lag3aida/aida mice, TT2-
Aicda+/ ES cells, TT2-Aicda/ ES cells, TT2 ES cells 
(maintained in our laboratory), and TT2 ES cells 
(purchased from a distributor) genomes. U, uncut; 
C, cut. Blue and red triangles indicate the bands 
from cut wild-type and mutant aida alleles, re-
spectively. Representative data of more than three 
independent experiments are shown. (E) Schematic 
representations of wild-type and aida mutant LAG-3  
proteins are shown. LAG-3 is composed of the 
extracellular region with four immunoglobulin-like 
domains, transmembrane region, and cytoplasmic 
region. (F) Predicted amino acid sequence of the 
aida mutant LAG-3 is shown in relation to the first 
immunoglobulin domain of wild-type LAG-3. A pre-
dicted signal sequence is boxed. Dashes represent 
no difference between the aida and wild-type LAG-3. Asterisk represents a premature stop codon. Cysteine residues involved in the immunoglobulin fold 
are marked by black dots. (G) Splenocytes from indicated mice were stimulated with 3 µg/ml of plate-bound anti-CD3 Abs for 24 h, and the expression of 
LAG-3 was analyzed by flow cytometry. Left dot plots are gated on CD4+ cells and right dot plots are gated on CD8+ cells. Representative flow cytometric 
profiles of three independent experiments are shown.JEM VOL. 208, February 14, 2011 
Article
399
cytotoxicity of NK cells against MHC class I–negative targets 
but normal in diverse aspects of T cell function. Because no 
spontaneous manifestation of autoimmunity has been re-
ported  for  Lag3/  mice,  we  backcrossed  the  C57BL/6-
Lag3/ mice on the BALB/c and NOD background. As 
expected, all of the BALB/c-Pdcd1/Lag3/ mice died of 
myocarditis  as  quickly  as  the  BALB/c-Pdcd1/Lag3aida/aida 
mice (Fig. 4, C and D), and the NOD-Lag3/ mice devel-
oped T1DM much earlier (Fig. 4 E) and showed more severe 
insulitis (Fig. 4 F) than the NOD wild-type mice. These re-
sults confirmed that the loss-of-function mutation in Lag3 
was responsible for the acceleration of autoimmunity that was 
originally linked to the Aicda knockout allele.
Hyperplasia of ILFs was dependent on AID deficiency  
but not aida mutation
The identification of the aida mutation on Lag3 may bring 
some previous studies using BALB-Aicda/ mice into ques-
tion. Aicda/ mice have been shown to develop hyperplasia 
of the ILFs with a 100-fold expansion of the anaerobic flora 
(Fagarasan et al., 2002). Examination of the small intestine re-
vealed a large number of enlarged ILFs in the intestines of the 
BALB/c-Aicda/ but not the BALB/c-Lag3aida/aida mice, in-
dicating that the hyperplasia of the ILFs was actually a result 
of AID  deficiency  and  not  of  LAG-3  deficiency  (Fig.  5). 
Consistent with this prediction, LAG-3 protein could not be 
detected on the surface of CD4+ or CD8+ T cells from aida mice 
(Fig. 3 G). LAG-3, a type I transmembrane protein that shares 
various features with CD4, is expressed on activated T cells, 
NK cells, and plasmacytoid DCs (Triebel et al., 1990; Miyazaki 
et al., 1996; Workman et al., 2002b). Although the precise sig-
naling mechanism is unclear, several groups have shown that 
LAG-3 negatively regulates T cell activation and proliferation   
(Hannier et al., 1998; Workman and Vignali, 2003; Workman   
et al., 2004; Grosso et al., 2007).  Therefore, it seemed very likely 
that this mutation was the causal mutation of the aida pheno-
type, and we therefore called this mutant allele Lag3aida.
Aida mutation exaggerated autoimmunity  
irrespectively of AID
We then segregated the Lag3aida/aida from Aicda/ to generate 
BALB/c-Pdcd1/Lag3aida/aida  and  NOD-Lag3aida/aida  mice. 
The BALB/c-Pdcd1/Lag3aida/aida mice died of myocarditis 
in a similar time course as the BALB/c-Pdcd1/Aicda/ 
Lag3aida/aida mice (compare Fig. 4 A with Fig. 1 A), and NOD-
Lag3aida/aida  mice  developed T1DM  as  quickly  as  NOD-
Aicda/Lag3aida/aida mice (compare Fig. 4 B with Fig. 1 C), 
indicating that the AID deficiency was not required for the 
acceleration of autoimmunity. Lag3/ mice were originally 
reported by Miyazaki et al. (1996) to be defective in the 
Figure 4.  LAG-3 deficiency causes the autoimmunity in aida mice. (A) Survival curves of BALB/c-Pdcd1/Lag3aida/aida (n = 13), BALB/c-Pdcd1/ 
Lag3+/aida (n = 14), and BALB/c-Pdcd1/ (n = 6) mice. (B) Type 1 diabetes incidence in NOD-Lag3aida/aida, NOD-Lag3+/aida, and NOD wild-type female  
(n = 12, 20, and 22, respectively) and male (n = 14, 38, and 16, respectively) mice. (C) Survival curves of BALB/c-Pdcd1/Lag3/ (n = 5), BALB/c-Pdcd1/ 
Lag3aida/ (n = 7), and BALB/c-Pdcd1/Lag3aida/aida (n = 3) mice. (D) Representative histology of the heart from BALB/c-Pdcd1/Lag3aida/aida, BALB/c-
Pdcd1/Lag3aida/, and BALB/c-Pdcd1/Lag3/ mice. (E) Type 1 diabetes incidence in NOD-Lag3/, NOD-Lag3+/, and NOD wild-type female (n = 15, 
25, and 11, respectively) and male (n = 17, 38, and 18, respectively) mice. (F) Percentage of islets with each grade of insulitis (0, 1, 2, and 3) in 8-wk-old 
female NOD mice with the indicated genotype. More than 100 islets from five Lag3/, three Lag3+/, and four wild-type mice were analyzed.400 LAG-3 influences autoimmunity in mice | Okazaki et al.
Augmented Th1 response in  
BALB/c-Pdcd1/Lag3aida/aida mice
To analyze the mechanisms of how compound deficiency of 
PD-1 and LAG-3 induces myocarditis, we first analyzed the 
activation status of splenocytes. LAG-3 deficiency slightly   
increased the number of lymphocytes on the BALB/c and 
NOD backgrounds in accordance with a previous study on 
C57BL/6-Lag3/ mice (Workman and  Vignali, 2005), whereas 
the number of lymphocytes was not increased in BALB/c-
Pdcd1/Lag3aida/aida mice (Fig. 7, A and B). The frequency of 
activated T cells (CD44+CD62L) in spleen was significantly 
increased in BALB/c-Pdcd1/Lag3aida/aida mice but not in 
NOD-Lag3aida/aida mice (Fig. 7, C and D). Next, we analyzed 
heart infiltrates and found that CD4+ and CD8+ T cells 
constituted 18.7 and 30.0% of heart infiltrates, respectively 
(Fig. 7 E), and they were highly activated judging from the 
expression profiles of CD62L and CD44 (Fig. 7 C).
Upon activation with PMA and ionomycin for 5 h, 
>40% of heart infiltrating CD4+ T cells and >80% of heart 
infiltrating CD8+ T cells produced IFN-, whereas IL-4– 
and IL-17–producing cells were much less (IL-4, 1.3 ± 
0.12% and 0.03 ± 0.00%; IL-17, 0.48 ± 0.13% and 0.08 ± 
0.02%, respectively for CD4+ and CD8+ T cells), suggest-
ing  that  heart-infiltrating  T  cells  were  biased  to  Th1   
(Fig. 7, F and G). Consistently, the inflamed heart con-
tained a larger amount of mRNA of IFN-, but not IL-1, 
However, the LAG-3 deficiency seemed to exaggerate the 
size of the ILFs formed in the intestines of BALB/c-Aicda/ 
mice because the number of large (>0.5 mm) ILFs, but   
not total ILFs, was significantly increased in the BALB/c-
Aicda/Lag3aida/aida mice compared with the BALB/c-Aicda/ 
mice (Fig. 5 B; P < 0.01 and P > 0.1, respectively). Spontane-
ous germinal center formation in the BALB/c-Aicda/ mice 
was also dependent on the AID deficiency and not the LAG-3 
deficiency because the number of PNA+ B cells in the spleen 
and Peyer’s patches are increased in BALB/c-Aicda/ but 
not  in  the  BALB/c-Lag3aida/aida  mice  (Fig.  S2;  Muramatsu   
et al., 2000; Fagarasan et al., 2002).
Gastritis and DCM of BALB/c-Pdcd1/ mice required  
SHM and CSR
At this point, we were able to examine the original question 
of whether AID deficiency affects the autoimmune pheno-
types of BALB/c-Pdcd1/ mice. Gastritis was almost com-
pletely abolished by the AID deficiency (Fig. 6), indicating 
that gastritis in BALB/c-Pdcd1/ mice requires autoAbs 
and/or  autoreactive  B  cells  that  have  undergone  SHM 
and/or  CSR.  Interestingly,  60%  of  the  BALB/c-Aicda/ 
Lag3aida/aida  mice,  but  none  of  the  BALB/c-Aicda/  or 
BALB/c-Lag3aida/aida mice, developed substantial gastritis. The 
incidence of DCM in BALB/c-Pdcd1/ mice varies from   
0 to 60% among colonies (Okazaki and Honjo, 2006). The 
incidence of DCM was 20% in the current colony of BALB/c- 
Pdcd1/ mice (N14) and 0% in the BALB/c-Pdcd1/ 
Aicda/  mice  (Fig.  S3). Therefore,  DCM  in  BALB/c-
Pdcd1/ mice also requires autoAbs and/or autoreactive   
B cells that have undergone SHM and/or CSR.
Figure 5.  Hyperplasia of ILFs is dependent on AID deficiency but 
not on LAG-3 deficiency. (A) Representative pictures of the ILFs in 
BALB/c wild-type, BALB/c-Aicda/, and BALB/c-Lag3aida/aida mice. Arrows 
indicate ILFs. (B) The number of total (left) and large (right, >0.5 mm) ILFs 
was evaluated in mice with the indicated genotype at 21–23 wk of age 
(n = 6 each). Each black symbol represents an individual mouse and the 
red bar represents the mean value for each group. *, P < 0.05. Figure 6.  Gastritis in BALB/c-Pdcd1/ mice requires autoAbs that 
have undergone SHM and/or CSR. (A) Incidence of gastritis of indicated 
grade (0, 1, 2, and 3) at 21–23 wk of age in BALB/c-Pdcd1/ (n = 10), 
BALB/c-Aicda/Pdcd1/ (n = 7), BALB/c-Aicda/Lag3aida/aida (n = 9), 
BALB/c-Aicda/ (n = 6), BALB/c-Lag3aida/aida (n = 6), and BALB/c wild-
type (n = 5) mice. (B) Representative histology of the stomach of BALB/c-
Pdcd1/ and BALB/c-Pdcd1/Aicda/ mice.JEM VOL. 208, February 14, 2011 
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Waterhouse et al., 1995; Huang et al., 2004). The frequency of 
CD25+FoxP3+ T reg cells was rather increased in BALB/c-
Pdcd1/Lag3aida/aida mice but unchanged in NOD-Lag3aida/aida 
mice compared with their controls (Fig. 8, A and B). The   
suppressive  function  of T  reg  cells  from  BALB/c-Pdcd1/ 
Lag3aida/aida mice was comparable to that of control T reg cells 
in an in vitro assay. In addition, responder cells from BALB/c-
Pdcd1/Lag3aida/aida and BALB/c wild-type mice were sup-
pressed to a similar extent by T reg cells from either BALB/c 
wild-type or BALB/c-Pdcd1/Lag3aida/aida mice (Fig. 8, C–F).
We then generated BM chimera of BALB/c-Pdcd1/ 
Lag3aida/aida and BALB/c wild-type mice, in which, theoreti-
cally, all kinds of regulatory cells originated from wild-type 
mice could be supplemented from the initiation step of auto-
immunity. Adoptive transfer of BM cells from BALB/c-
Pdcd1/Lag3aida/aida mice into immunodeficient mice induced 
myocarditis within 6 wk. Strikingly, cotransfer of BM cells 
from BALB/c wild-type or BALB/c-Lag3aida/aida mice failed 
to suppress myocarditis, suggesting that myocarditis in BALB/c- 
Pdcd1/Lag3aida/aida mice was not the result of a failure in 
cells with regulatory function (Fig. 8, G and H).
LAG-3 and PD-1 act synergistically to suppress  
T cell activation
To elucidate the co-operative roles of LAG-3 and PD-1, we 
examined the expression of these inhibitory receptors on T cells. 
Although these receptors were rarely expressed on freshly iso-
lated T cells, they were rapidly induced on both CD4+  
and CD8+ T cells upon stimulation with anti-CD3 Ab. Co-
stimulation through CD28 up-regulated the expression level 
of these molecules. Interestingly, LAG-3 induction required a 
weaker stimulation than PD-1 induction (Fig. 9, A and B).
Next, we examined the inhibitory function of these re-
ceptors using DO11.10 cells that recognize OVA peptide on 
MHC class II molecule but lack CD4 expression. Because 
DO11.10 cells constitutively expressed PD-1 but not LAG-3, 
we introduced mouse LAG-3 cDNA into DO11.10 cells by 
retroviral infection. We also introduced mouse PD-L1 cDNA 
into IIA1.6 cells, an Fc receptor–negative B cell line, and used 
them for antigen presentation. LAG-3 and PD-1 suppressed 
IL-2 production by DO11.10 cells upon antigen stimulation. 
In addition, co-engagement of LAG-3 and PD-1 further sup-
pressed IL-2 production, suggesting that LAG-3 and PD-1   
act synergistically to suppress antigen stimulation of CD4+  
T cells (Fig. 9 C). We also examined the inhibitory function of 
LAG-3 using a CD4-positive cell line, 2B4.11 cells, that rec-
ognize a cytochrome c peptide. LAG-3 clearly inhibited IL-2 
production by 2B4.11 cells upon antigen stimulation (Fig. S4).
We then examined the function of PD-1 and LAG-3   
using primary mouse T cells. Naive CD4+ T cells from 
DO11.10 transgenic mice that lack PD-1, LAG-3, or both 
were stimulated with antigen-loaded IIA1.6 cells expressing 
PD-L1. PD-1 and LAG-3 significantly inhibited proliferative 
response of primary DO11.10 T cells upon antigen stimula-
tion. We could also observe an additive effect of PD-1 and 
LAG-3 (Fig. 9, D and E).
IL-4, IL-17, and TNF, compared with the spleen of control 
mice (Fig. 7 H).
T reg cells were normal in BALB/c-Pdcd1/Lag3aida/aida mice
Because LAG-3 has been shown to play a role in T reg cell 
function and myocarditis is one of the frequent phenotypes   
of T reg cell failure, we analyzed the function of T reg cells   
in BALB/c-Pdcd1/Lag3aida/aida mice (Tivol et al., 1995;   
Figure 7.  Augmented Th1-response in BALB/c-Pdcd1/Lag3aida/aida 
mice. (A and B) The absolute number (A) and frequency (B) of each cell 
fraction in spleen of mice of indicated genotypes at 3–6 wk of age.  
(C and D) Frequencies of activated (CD62LCD44+) and naive (CD62L+CD44) 
CD4+ and CD8+ T cells in spleen of mice of indicated genotypes. (E) Fre-
quencies of indicated cell fraction in CD45+ heart infiltrates from BALB/c-
Pdcd1/Lag3/ mice are shown. (F and G) Frequencies of CD4+ and 
CD8+ T cells that produced IFN-, IL-4, and IL-17 upon ex vivo stimulation. 
Splenocytes of BALB/c-Pdcd1+/Lag3+/ and BALB/c-Pdcd1/ 
Lag3/ mice and heart infiltrates of BALB/c-Pdcd1/Lag3/ mice were 
analyzed. Representative flow cytometric profiles are shown in G.  
(H) Quantities of mRNA encoding indicated genes in inflamed hearts of BALB/c- 
Pdcd1/Lag3aida/aida mice relative to that in spleens of BALB/c wild-type 
mice. Data are mean ± SEM (A–F) or mean + SEM (H). N.D., not detected. 
**, P < 0.01; *, P < 0.05. At least three mice of each genotype were analyzed 
in each experiment. Data of three BALB/c-Pdcd1/Lag3aida/aida and seven 
BALB/c-Pdcd1/Lag3/ mice are combined in A–C.402 LAG-3 influences autoimmunity in mice | Okazaki et al.
Recently, LAG-3 has attracted increasing atten-
tion. LAG-3 was reported to negatively regulate the 
function of CD4+ T cells, CD8+ T cells, and plasma-
cytoid DCs (Grosso et al., 2007; Workman et al., 
2009) and to regulate the homeostatic proliferation 
of CD8+ T cells and the suppressive activity of T reg 
cells  (Huang  et  al.,  2004; Workman  and Vignali, 
2005). However, the effect of LAG-3 in these assays 
is  relatively  small,  and  the  actual  contribution  of 
LAG-3  to  the  regulation  of  immune  system  has 
been unclear. In the current study, the LAG-3 deficiency was 
accidentally coupled with the PD-1 deficiency in vivo, which 
led us to discover that the inhibitory signal through LAG-3 is 
actually indispensable for robust immunological self-tolerance.
LAG-3 has been shown to play a role in T reg cell func-
tion, and myocarditis is one of the frequent phenotypes of   
T reg cell failure (Tivol et al., 1995; Waterhouse et al., 1995; 
Huang et al., 2004). In Ctla4/ mice, spleens and lymph 
nodes are extremely enlarged (5–10-fold enlargement) and 
most of the peripheral T cells are activated and invade various 
organs, including the heart, resulting in the premature death 
around 3 wk of age (Tivol et al., 1995; Waterhouse et al., 
1995). The polyclonal activation of T cells in Ctla4/ mice is 
most likely a result of the dysfunction of T reg cells because 
immunodeficient  mice  reconstituted  with  the  mixed  BM 
cells from wild-type and Ctla4/ mice failed to develop the 
fatal disease of the Ctla4/ mice and the deletion of the 
CTLA-4 gene in FoxP3+ T reg cells recapitulated the fatal 
disease of the Ctla4/ mice (Bachmann et al., 1999; Wing   
et al., 2008). Phenotypes of BALB/c-Pdcd1/Lag3aida/aida 
mice are somehow different from those of Ctla4/ mice. In 
BALB/c-Pdcd1/Lag3aida/aida mice, the increase of splenocytes 
DISCUSSION
In the current study, we have accidentally isolated a mouse line 
that  spontaneously  develops  autoimmune  diseases  under  the 
presence of other autoimmune susceptibility, named this line aida 
for AID-linked autoimmunity, and pursued its causal gene. After 
careful examination of neighboring genes of Aicda, we identified 
Lag3 as a causal gene of aida mice. As summarized in Table S2, 
LAG-3 deficiency, but not AID deficiency, induced lethal myo-
carditis in the absence of PD-1 on the BALB/c background and 
it also exaggerated the onset and the penetrance of T1DM on the 
NOD background. LAG-3 is a type I transmembrane protein 
that shares various features with CD4. Lag3/ mice were origi-
nally reported to be defective in the cytotoxicity of NK cells 
against MHC class I–negative targets but normal in diverse as-
pects of T cell function including positive and negative selection 
of T cells in thymus, numbers and distribution of peripheral 
CD4+ and CD8+ T cells, their activated and memory subpopula-
tions and their responses to mitogens and antigen priming, B cell 
maturation and distribution, and Ab production after primary 
and secondary immunization by Miyazaki et al. (1996). Because 
the phenotype was much weaker than that of Cd4/ mice, 
LAG-3 was not analyzed vigorously until recently.
Figure 8.  T reg cells were normal in BALB/c-Pdcd1/ 
Lag3aida/aida mice. (A and B) Frequencies of CD25+FoxP3+  
T cells among CD4+ T cells in spleen of wild-type (n = 9 and 9 
for BALB/c and NOD, respectively), Lag3aida/aida (n = 6 and 9 for 
BALB/c and NOD, respectively), and Pdcd1/Lag3/ (n = 10; 
seven BALB/c-Pdcd1/Lag3/ and three BALB/c-Pdcd1/ 
Lag3aida/aida) mice. Representative flow cytometric profiles are 
shown in A. Data are mean ± SEM. **, P < 0.01. (C–F) In vitro 
suppressor assay using CD4+CD25+ T reg cells and CFSE- 
labeled CD4+CD25 effector cells (Teffs) from mice with the 
indicated genotype. The numbers on the x-axis indicate the 
ratio of CD4+CD25+ T reg cells to CD4+CD25 effector T cells. 
WT, BALB/c wild-type; PL, BALB/c-Pdcd1/Lag3aida/aida; aida, 
BALB/c-Lag3aida/aida mice. Representative flow cytometric pro-
files of CFSE dilution (C and E). Mean ± SD of triplicate cultures 
are shown (D and F). Representative data of four (C and D)  
and two (E and F) independent experiments are shown.  
(G and H) Myocarditis in BALB/c-Rag2/ mice reconstituted 
with BM from BALB/c-Pdcd1/Lag3aida/aida and/or BALB/c wild-
type mice. The frequency of myocarditis (H) and representative 
histology (G) are shown for BALB/c-Rag2/ mice reconsti-
tuted with BM cells from BALB/c-Pdcd1/Lag3aida/aida mice  
(n = 11), mixed BM cells from BALB/c-Pdcd1/Lag3aida/aida and 
wild—type mice (n = 11), and mixed BM cells from BALB/c-
Pdcd1/Lag3aida/aida and BALB/c-Lag3aida/aida mice (n = 6).JEM VOL. 208, February 14, 2011 
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suppressed well by T reg cells in vitro. In addition, immuno-
deficient mice reconstituted with the mixed BM cells from 
BALB/c-Pdcd1/Lag3aida/aida and wild-type mice developed 
lethal myocarditis. These results do not support the idea that 
the main cause of the lethal myocarditis in BALB/c-Pdcd1/ 
Lag3aida/aida mice is the failure in regulatory cells by the loss of 
these negative receptors.
Coexpression of PD-1 and LAG-3 on CD8+ T cells was 
recently reported by three groups (Blackburn et al., 2009; 
Grosso et al., 2009; Richter et al., 2010). Blackburn et al. 
(2009)  reported  that  exhausted  CD8+ T  cells  in  a  mouse 
model of chronic lymphocytic choriomeningitis virus (LCMV) 
infection express seven kinds of inhibitory immunoreceptors, 
including PD-1 and LAG-3. They also showed that PD-1 
blockade partially reverses the exhaustion of CD8+ T cells. 
Although the effect of LAG-3 blockade alone was marginal, 
the simultaneous blockade of PD-1 and LAG-3 resulted in a 
better reversal of exhaustion than the blockade of PD-1 alone. 
Richter et al. (2010) also reported that LAG-3 is highly ex-
pressed on exhausted LCMV-specific CD8+ T cells. However, 
they reported that chronic LCMV infection of Lag3/ mice 
led to a comparable degree of T cell exhaustion and to similar 
virus titers as observed in control mice. Grosso et al. (2009) 
reported that PD-1 and LAG-3 showed sustained expression 
on CD8+ T cells after stimulation with tolerizing environ-
ment. Although the final effector cells of the myocarditis in 
BALB/c-Pdcd1/Lag3aida/aida mice was CD4+ T cells and not 
CD8+ T cells, a similar scenario may occur in the current 
model as well. In fact, we found the coexpression of PD-1 
and LAG-3 on both activated CD4+ and CD8+ T cells. We 
also observed synergistic effects of PD-1 and LAG-3 on the 
inhibition of T cell activation upon antigen stimulation using 
T cell lines and primary DO11.10 T cells, suggesting that 
LAG-3 and PD-1 regulate the activation of CD4+ T cells 
concurrently. Because heart-infiltrating CD4+ T cells were 
strongly biased to Th1, these receptors may suppress the Th1 
response of CD4+ T cells. Interestingly, LAG-3 induction re-
quired a weaker stimulation than PD-1 induction. It is possi-
ble that LAG-3 primarily responds to autoimmune stimuli 
and renders autoreactive T cells unresponsive, whereas PD-1 
functions as a fail-safe device that suppresses adversely acti-
vated autoreactive T cells. In summary, LAG-3 and PD-1 most 
likely inhibit the activation and/or expansion of heart-reactive 
CD4+ T cells to prevent myocarditis in BALB/c mice.
The structure of LAG-3 is quite similar to CD4 and LAG-3 
is reported to bind to MHC class II (Baixeras et al., 1992; 
Huard et al., 1997). We found no detectable changes in the 
negative selection of super antigen-reactive T cells in Lag3aida/aida 
mice in accordance with the previous description (Miyazaki 
et al., 1996; Fig. S5), suggesting that LAG-3 deficiency may 
affect peripheral tolerance rather than central tolerance.   
In our in vitro experimental system, LAG-3 suppressed anti-
gen stimulation in both CD4-positive and -negative cells, as 
opposed to a previous study (Workman et al., 2002a), indicat-
ing that the inhibitory mechanisms of LAG-3 cannot be to-
tally attributed to the competition for MHC class II binding 
was marginal. T cells were highly activated in heart but   
their activation was rather modest in spleen compared with 
Ctla4/ mice. In addition, hearts are preferentially attacked 
in BALB/c-Pdcd1/Lag3aida/aida mice, whereas various organs 
are affected in Ctla4/ mice. T reg cells from BALB/c-Pdcd1/ 
Lag3aida/aida mice had substantial suppressive function and   
responder  cells  from  BALB/c-Pdcd1/Lag3aida/aida  were   
Figure 9.  LAG-3 and PD-1 act synergistically to suppress CD4+  
T cell activation. (A and B) Splenocytes were stimulated with the indi-
cated concentrations (µg/ml) of plate-bound anti-CD3 Ab in the absence 
(A) or presence (B) of soluble anti-CD28 Ab for 48 h, and the expression of 
LAG-3 and PD-1 was analyzed by flow cytometry. Plots are gated on CD4+ 
or CD8+ cells where indicated. Representative data from two independent 
experiments are shown. (C) DO11.10 cells transduced or not with LAG-3–
expressing retrovirus, were stimulated with OVA peptide–pulsed IIA1.6 
cells, transduced or not with PD-L1–expressing retrovirus. T cell IL-2 pro-
duction was measured by ELISA. Data are the mean ± SEM of duplicate 
wells. Representative data of two independent experiments are shown.  
(D and E) Naive CD4+ T cells were sorted from DO11.10 TCR transgenic 
mice lacking PD-1, LAG-3, or both. Cells were labeled with CFSE and stim-
ulated with IIA1.6–PD-L1 cells pulsed with 0.3 µM OVA peptide. After 2 d, 
cells were analyzed by flow cytometry. Representative CFSE dilution pro-
files are shown in D. The frequency of cells with more than three divisions 
was compared among four genotypes (E). Data are mean ± SEM of tripli-
cate wells. Representative data of two independent experiments are 
shown. **, P < 0.01 compared with the other three groups.404 LAG-3 influences autoimmunity in mice | Okazaki et al.
not require antigen presentation from B cells to induce  T1DM 
because  they  are  readily  activated  by  other  types  of  cells, 
which are supposed to be less effective in presenting  cell 
antigens than B cells.
In the current study, we happened to realize that our 
colony of BALB/c-Aicda/ mice had acquired the loss-
of-function mutation in a neighboring gene encoding LAG-3 
during the process of backcrossing on BALB/c background. 
Recently, Hase et al. (2008) reported that BALB/c-Aicda/ 
mice develop gastritis. In light of the discovery of the aida 
mutation, it is likely that they were observing the effect of   
the combined deficiency of AID and LAG-3. However, hy-
perplasia of the ILFs and the increase of germinal center   
B cells in Aicda/ mice were confirmed to be dependent on 
AID deficiency.
The difference in the genetic background has substantial 
effects on various biological activities. Recently, more and 
more genetically manipulated mice are backcrossed from one 
strain to other strains to analyze the function of the manipu-
lated genes on different genetic backgrounds. In the course   
of backcrossing, we may have spontaneous mutations in 
neighboring genes as we experienced in the current study. 
The effects of these mutations can be mistakenly interpreted 
as the effects of manipulated genes because these mutations 
are strongly linked to manipulated genes. In addition, such a 
genetic influence does not need to be an acquired mutation; 
a donor strain–derived polymorphism can also make a strong 
effect. In fact, we cannot fully exclude the possibility that the 
enlargement of ILFs in BALB/c-Aicda/Lag3aida/aida mice is 
the result of a CBA-derived polymorphism in the narrow re-
gion containing Lag3 rather than the dysfunction of LAG-3. 
Current observation represents another caveat for the inter-
pretation of studies using genetically engineered animals with 
many backcrosses and passages.
In summary, our current findings provide direct evidence 
that LAG-3 is a critical regulator of autoimmunity and that 
synergistic actions of LAG-3 and PD-1 are critical for the 
prevention of autoimmunity. These two receptors therefore 
represent potential therapeutic targets for autoimmunity, in-
fectious immunity, tumor immunity, and transplantation.
MATERIALS AND METHODS
Animals. BALB/c-Pdcd1/ mice (N14), which were generated by back-
crossing BALB/c-Pdcd1/ mice (N10; Nishimura et al., 2001) on BALB/c 
mice for four generations, were crossed with BALB/c-Aicda/ mice (N10). 
The BALB/c-Aicda/ mice (N10; Fagarasan et al., 2002) were backcrossed on 
NOD mice for more than six generations. NOD-MT and NOD-SCID 
mice were purchased from The Jackson Laboratory and Japan Clea, respectively. 
NOD-Aicda/ mice were further backcrossed on NOD mice, and the NOD-
Lag3aida/aida mice were separated from the NOD-Aicda/Lag3aida/aida mice at 
N14. C57BL/6-Lag3/ mice were provided by D.  Vignali (St. Jude Children’s 
Research Hospital, Memphis, TN), C. Benoist, and D. Mathis (Harvard Medical 
School, Boston, MA; Miyazaki et al., 1996; Workman et al., 2004). C57BL/6-
Lag3/ mice were backcrossed on BALB/c mice for three (Fig. 4) and seven 
(Figs. 7 and 8) generations and on NOD mice for six generations. Genotypes at 
Idd1, 3, 5, and 9 were monitored, and those with NOD-derived alleles were 
selected.  DO11.10 TCR  transgenic  mice  were  provided  by  K.  Murphy   
(Washington University School of Medicine, St. Louis, MO) and Y. Wakatsuki 
with CD4. Because the region in the cytoplasmic tail of 
LAG-3 that has been reported to be critical for its inhibitory 
function does not include any well defined signaling motifs 
(Workman et al., 2002a), LAG-3 may transduce a unique in-
hibitory signal that has not been characterized yet.
Because isotype-switched and somatically mutated autoAbs 
are frequently found in human patients and model animals   
of autoimmune diseases, SHM and CSR are supposed to   
be essential for the development of these diseases. However, it 
is still controversial whether the lack of SHM and CSR alle-
viates autoimmunity or not. Jiang et al. (2007) reported that 
MRL-Faslpr/lprAicda/ mice developed much milder glo-
merulonephritis and survived longer compared with AID- 
sufficient littermates, indicating that CSR and SHM are 
essential for the development of glomerulonephritis in MRL-
Faslpr/lpr mice. Interestingly, MRL-Faslpr/lprAicda/ mice pro-
duced a five-times-higher amount of anti-dsDNA IgM than 
AID-sufficient littermates, suggesting that larger amount of 
unmutated IgM autoAbs cannot compensate for isotype-
switched and mutated autoAbs in the development of glo-
merulonephritis in MRL-Faslpr/lpr mice. On the contrary, 
Chen et al. (2010) reported that AID deficiency exacerbated 
glomerulonephritis in C57BL/6-Faslpr/lpr mice, which develop 
milder phenotypes compared with MRL-Faslpr/lpr mice. In the 
current study, we found that SHM and/or CSR are required 
for  the  development  of  gastritis  and  DCM  in  BALB/c-
Pdcd1/ mice in accordance with our previous findings that 
IgG autoAbs against cardiac troponin I are responsible for   
the DCM in BALB/c-Pdcd1/ mice and IgG antiparietal 
cell autoAbs are highly produced in BALB/c-Pdcd1/ mice 
with gastritis (Okazaki et al., 2003, 2005). Further analyses   
on BALB/c-Pdcd1/ mice may elucidate the mechanisms of 
how autoreactive B cells escape from deletion, are activated, 
undergo SHM and CSR, and eventually induce overt auto-
immune diseases by PD-1 deficiency.
In contrast, SHM and CSR were not required for the de-
velopment of T1DM in NOD-Lag3aida/aida mice and myocar-
ditis in BALB/c-Pdcd1/Lag3aida/aida mice. Interestingly, B cells 
themselves were not required for T1DM in NOD-Lag3aida/aida 
mice because they developed T1DM very early in the absence 
of B cells. NOD-Aicda/ mice apparently developed T1DM 
more slowly in the absence of B cells. Because the spontane-
ous dissociation of Aicda and Lag3aida occurred in the colony 
of NOD-MT-Aicda/ but not NOD-Aicda/ mice, the 
delay was most likely a result of the emergence of segregants 
but not of the lack of B cells. It is widely accepted that B cells 
play critical roles in T1DM of NOD mice because NOD-
MT mice that lack mature B cells have a very low incidence 
of T1DM and have a delay and reduction in the severity of 
insulitis (Serreze et al., 1996; Akashi et al., 1997; Yang et al., 
1997). Wong et al. (2004) provided direct evidence that the 
role of B cells in T1DM of NOD mice relates to their func-
tion as antigen-presenting cells rather than to the production 
of autoAbs. They postulated that the antigen-specific antigen 
presentation by B cells may efficiently stimulate cognate   
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Laboratories, Abs against LAG-3, IL-4, IFN-, Gr1, PD-1, Mac1, and CD62L 
were purchased from eBioscience, and all the other Abs used in this study 
were purchased from BioLegend.
Real-time PCR. Total RNA was isolated from spleens of BALB/c wild-
type mice and inflamed hearts of BALB/c-Pdcd1/Lag3aida/aida mice using 
TRIzol (Life Technologies) and single-strand cDNA was synthesized using 
High-Capacity cDNA Reverse Transcription kits according to the man-
ufacturer’s instruction (Life Technologies). Gene expression profiling was   
performed using Taqman Low Density Array Immuno Profiling Plate (Life 
Technologies) and the comparative cycle threshold (Ct) method as described 
previously (Wang et al., 2010). The hypoxanthine guanine phosphoribosyl 
transferase (Hprt) was used as an endogenous control and the calibrator sam-
ples were spleens of age-matched BALB/c wild-type mice.
In vitro stimulation. Splenocytes were stimulated with plate-bound anti-
CD3 Abs (2C11) with or without soluble anti-CD28 Abs at the indicated 
concentration, and PD-1 and LAG-3 on the surface were detected 1-3 d later. 
Mouse LAG-3 cDNA was cloned by PCR and introduced into DO11.10 
and  2B4.11  cells  by  retroviral  infection.  Control  vector  lacking  LAG-3 
cDNA was used. Mouse PD-L1 cDNA was cloned by PCR and introduced 
into IIA1.6 cells, an Fc receptor–negative mouse B cell line. Cognate OVA 
peptide (ISQAVHAAHAEINEAGR, >95% purity) and cytochrome c pep-
tide (ANERADLIAYLKQATK, >95% purity) were synthesized by Sigma-
Aldrich. DO11.10 cells with or without LAG-3 (5 × 104 cells/well) were 
stimulated with peptide-pulsed IIA1.6 cells with or without PD-L1 (104 
cells/well) for 24 h. The amount of IL-2 in the culture supernatant was quan-
tified by ELISA (BioLegend). BM-derived DCs were generated from C3H/
HeN mice (Japan SLC) as described previously (Denda-Nagai et al., 2002) 
and used for the stimulation of 2B4.11 cells. Primary CD4+ T cells expressing 
DO11.10 TCR were prepared from mice with indicated genotype. We sorted 
naive (CD4+CD62L+) cells using MoFlo XDP (Beckman Coulter), labeled 
with CFSE (Life Technologies), and stimulated with peptide-pulsed IIA1.6-
PD-L1 cells treated with mitomycin C (Kyowa Hakko Kirin). We analyzed 
the dilution of CFSE 2 d later.
In vitro T reg cell assay. The in vitro T reg cell assay was performed as pre-
viously  described  (Sakaguchi  et  al.,  1995; Yoshida  et  al.,  2008).  In  brief, 
CD4+CD62L+CD25 effector T cells and CD4+CD62L+CD25+ T reg cells 
were prepared from mice with the indicated genotype using MoFlo XDP.   
T cell–depleted spleen cells from BALB/c wild-type mice were treated with 
mitomycin C and used as APCs. The purity of the prepared cells was >97%. 
CFSE-labeled CD25 effector T cells (2.5 × 104 cells) and 5 × 104 APCs 
were cultured in 96-well plates for 3 d with 1.0 µg/ml anti-CD3 Ab (2C11). 
CD25+ T reg cells were added to the culture at the indicated ratio against 
CD25 T cells. Suppression efficiency was calculated by dividing the fre-
quency of proliferating cells in the presence of T reg cells by that in the   
absence of T reg cells.
Statistics. The two-tailed unpaired Student’s t test was used to evaluate   
statistical significance.
Online Supplemental Material. Fig. S1 shows the mild lymphocytic 
infiltration in the stomach, salivary gland, pancreas, lung, and liver in ad-
dition to the heart of BALB/c-Pdcd1/Aicda/ mice. Fig. S2 shows the 
spontaneous  generation  of  germinal  centers  in  BALB/c-Aicda/  but 
not in BALB/c-Lag3aida/aida mice. Fig. S3 shows the protection of BALB/c- 
Pdcd1/  mice  from  DCM  by AID  deficiency.  Fig.  S4  shows  the  sup-
pression of IL-2 production by LAG-3 in 2B4.11 cells that express CD4.   
Fig. S5 shows the normal negative selection of superantigen reactive T cells 
in BALB/c -Lag3/ and BALB/c-Lag3aida/aida mice. Table S1 shows the 
list of genes in the region between Aicda and rs37864878. Table S2 sum-
marizes the responsible genes for each phenotype observed in the current 
study. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20100466/DC1.
(Kyoto University, Kyoto, Japan; Murphy et al., 1990). All the mouse protocols 
were approved by the Institute of Laboratory Animals, Graduate School of   
Medicine, Kyoto University and the Animal Experimentation Committee of   
the University of Tokushima. The mice were maintained under SPF conditions.
Assessment  of T1DM  and  histological  analysis. Urine glucose was 
monitored every week using Uropiece S (Astellas) and mice were considered 
diabetic after two consecutive measurements over 100 mg/dl. Mice were 
sacrificed when they became moribund for the pathological examination of 
BALB/c-Pdcd1/Lag3aida/aida mice, or at 7–8 wk of age for the evaluation of 
insulitis. Organs were fixed in 10% buffered formalin, processed, and embed-
ded in paraffin. Sections were stained with H&E using standard techniques. 
Insulitis was scored as described previously (Wang et al., 2005). In brief, peri-
insulitis, moderate insulitis, and severe insulitis were scored as 1, 2, and 3, re-
spectively. Gastritis was evaluated as described previously (Jiang et al., 2009).
Evaluation of ILF. Small intestines were filled with 10% formalin in PBS 
for 5 min before being opened longitudinally, as previously described (Oshima   
et al., 1996). The opened intestines were further fixed with 10% formalin in 
PBS for >14 h, and the ILFs on the inside of the intestines were observed 
under a microscope.
SNPs and microsatellite markers. Information on SNPs and microsatel-
lite markers were obtained from Mouse Phenome Database (http://phenome 
.jax.org/)  and  the  Sloan-Kettering  Mouse  Project  (https://mouse.mskcc 
.org/), respectively. For SNPs, we synthesized appropriate primer sets (Life 
Technologies), amplified DNA fragments using PCR (GeneAmp 9700; Life 
Technologies), and determined their sequence (Genetic Analyzer 3130xl; 
Life Technologies). For microsatellite markers, we synthesized primer sets, 
amplified DNA fragments using PCR, and separated on 4% agarose gels.
RFLP. The LAG-3 gene was amplified by PCR using the following primers: 
5-CTGACGGTCAAGAGGTCTCTTAGG-3  and  5-CTACACTTCT-
GGAGGTCCTCAGAC-3. The PCR fragments were digested with XhoI 
(Takara Bio Inc.) and separated on 2.5% agarose gels.
Transfer experiments. CD4+ T cells and CD4-depleted splenocytes were 
prepared from moribund BALB/c-Pdcd1/Aicda/Lag3aida/aida mice using 
anti-CD4 microbeads (Miltenyi Biotec). Unfractionated splenocytes (2 × 107), 
CD4+ T  cells  (0.8  ×  107,  >95%  pure  and  <0.3%  contamination  of   
CD8+ T cells on average), or CD4-depleted splenocytes (1.6 × 107, <0.5% 
contamination of CD4+ T cells on average) were transferred intravenously 
into  4–6-wk-old  BALB/c-Rag2/  mice.  BM  cells  were  prepared  from   
4-wk-old NOD-Aicda/Lag3aida/aida or NOD wild-type mice and 1.5 × 107 
BM cells were transferred intravenously into sublethally irradiated (3.5 Gy) 
NOD-SCID or NOD-SCID-Aicda/ mice. We prepared BM cells from 
mice with indicated genotype and depleted mature CD4+ and CD8+ T cells 
using magnetic beads (BD; <0.2% and <0.02% contamination of CD4+ and 
CD8+ T cells, respectively, on average). We transferred 0.5 × 107 BM cells 
from BALB/c-Pdcd1/Lag3aida/aida mice intravenously into sublethally irra-
diated (3.5 Gy) BALB/c-Rag2/ mice with or without the same number of 
BM cells from BALB/c wild-type or BALB/c-Lag3aida/aida mice. Recipient 
mice were analyzed 5–7 wk after the transfer.
Flow cytometric analysis. Heart infiltrates were prepared as described 
previously (Wang et al., 2010). Splenocytes, heart infiltrates, and Peyer’s patch 
cells were stained with the indicated Abs. Data were obtained with FACS-
Calibur (BD) or Gallios (Beckman Coulter) and analyzed using CellQuest 
(BD) or FlowJo (Tree Star, Inc.). Cytoplasmic staining was performed as   
described previously (Wang et al., 2005). In brief, splenocytes and heart infil-
trates were stimulated with 10 ng/ml PMA and 1 µg/ml ionomycin for 5 h 
with Monensin (BioLegend), stained with the indicated Abs, and analyzed   
by Gallios. Nuclear FoxP3 was detected using a staining kit according to   
the manufacturer’s instruction (BioLegend). Abs against CD28, and  Vs, were 
purchased  from  BD,  biotin-conjugated  PNA  was  purchased  from Vector   406 LAG-3 influences autoimmunity in mice | Okazaki et al.
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